STELARA
90mgSTELARA90mg
STELARA (ustekinumab) is an IL-12/23 inhibitor for psoriasis, psoriatic arthritis, and inflammatory bowel disease.
Key Benefits
- Dual IL-12/23 blockade
- Infrequent maintenance dosing
- Multiple indications
- Durable responses
Contact Us for Pricing
Get a written quote against a prescription within 24 hours for STELARA 90mg. Our team is available 24/7.
Direct line: +44 7429 917553
Prescription required
We do not proceed without one
Licensed Türkiye channels
İTS serial-traceable by karekod
Delivered in person
Not shipped by courier
Written reply
Quote within 24 hours
About STELARA 90mg
STELARA (ustekinumab) 90mg by Janssen is a unique biologic that blocks both IL-12 and IL-23, two cytokines central to the pathogenesis of psoriatic disease and inflammatory bowel conditions. This dual mechanism provides comprehensive control of inflammation with the convenience of infrequent dosing after initial loading. STELARA is approved for plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. We supply authentic STELARA with complete cold chain integrity and competitive pricing for healthcare distributors worldwide.
Common Uses
- Plaque psoriasis
- Psoriatic arthritis
- Crohn's disease
- Ulcerative colitis
Related Rheumatology & Immune Products
Explore more rheumatology & immune medications from our catalog
